News & Updates
Filter by Specialty:
Novel miRNA signature reliably detects lethal pancreatic cancer in the early stages
An exosome-based liquid biopsy showed favourable signals for noninvasive, early detection of pancreatic ductal adenocarcinoma (PDAC) in a prospective study.
Novel miRNA signature reliably detects lethal pancreatic cancer in the early stages
14 Jun 2024
Blood-based CRC screening platform delivers promising performance
An investigational blood-based test performs satisfactorily for the early detection of colorectal cancer (CRC), having met all prespecified primary endpoints in the large PREEMPT CRC trial.
Blood-based CRC screening platform delivers promising performance
13 Jun 2024
Intense exercise safe for men with metastatic prostate cancer
Patients with metastatic prostate cancer can safely engage in intense exercise training to improve survival outcomes, suggests a study presented at AACR 2024.
Intense exercise safe for men with metastatic prostate cancer
13 Jun 2024
Are fertility treatments safe in young breast cancer survivors who have high-risk genes?
In young breast cancer survivors harbouring BRCA1/2 pathogenic variants, using assisted reproductive techniques (ART) to conceive did not appear to negatively affect maternal or pregnancy outcomes, findings from an international retrospective cohort study suggest.
Are fertility treatments safe in young breast cancer survivors who have high-risk genes?
13 Jun 2024
Olaparib extends survival in gBRCA-mutated breast cancer
The intermittent 48-h “gap” schedule of olaparib in combination with carboplatin/paclitaxel and anthracycline chemotherapy provides substantial survival benefits in patients with germline BRCA-mutated breast cancer (gBRCA) regardless of their pathological complete response (pCR) status, results of the PARTNER trial have shown.